Liquid Biopsy for Early Detection of Colorectal Cancer Using Circular RNA
This is not medical advice. AI-assisted translation — inaccuracies may occur. Always verify the original and consult your oncologist before taking any steps.
About the trial
Colorectal cancer (CRC) is a leading cause of cancer-related deaths worldwide. This study aims to develop a non-invasive liquid biopsy assay using plasma-derived cell-free circular RNAs (cf-circRNAs) for early and accurate detection of colorectal cancer.
Original English text from ClinicalTrials.gov
Who can (and can't) join
✓ Qualifies
- •Osoby dorosłe (powyżej 18 lat)
- •Potwierdzony rak jelita grubego (wczesne stadia)
- •Dostępne próbki krwi pobrane przed leczeniem
- •Wyrażenie pisemnej zgody na udział w badaniu
✗ Disqualifies
- •Inny aktywny nowotwór w ciągu ostatnich 5 lat
- •Zła jakość próbki krwi (np. rozpad czerwonych krwinek)
- •Brak możliwości udzielenia świadomej zgody
Simplified criteria — AI translation
Trial details
- Minimum age
- 18 Years
- Last updated (source)
- July 7, 2026
- Sex
- No restrictions
Therapies / drugs in trial
Locations (1)
City of Hope Medical Center
Duarte, United States
Trial contact
Goel Ajay, PhD
Contact information from ClinicalTrials.gov. Contact in English.
Share this trial
Data from ClinicalTrials.gov. AI-assisted translation, last sync: 7/8/2026.
You can help another person
We fund the Radar, this site, and the development of our Grosz dla Życia fundraising platform from donations and our own resources. Every contribution, even a small one, really helps.